The deregulation of CSNK1D expression or function has been observed in cancer, but also in several other pathologies like Alzheimer's disease or familial advanced sleep phase syndrome [38, 39]. The gene discussed is CSNK1D; the disease is early-onset autosomal dominant Alzheimer disease.